KATIE PAVLISKO: Open Payments
NPI 1831224575 · PITTSFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 20 payments from 7 companies in 2025. Trend: 2023 $361 · 2024 $767 · 2025 $1,060
Food & beverage: $993Education: $67
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $237 |
| Janssen Biotech, Inc. | 2 | $154 |
| Novartis Pharmaceuticals Corporation | 7 | $148 |
| Incyte Corporation | 1 | $140 |
| GENZYME CORPORATION | 2 | $138 |
| Organon LLC | 4 | $122 |
| Galderma Laboratories, L.P. | 2 | $121 |
Products named: TREMFYA, OPZELURA, DUPIXENT, NEMLUVIO, VTAMA, Bimzelx, COSENTYX, Rhapsido.
Industry payments across NY — which companies pay providers there.
